Brand: Health Concerns

Tablet or PillOn Market
Click to view full label

Net Contents

90 Tablet(s)

Serving Size

3 Tablet(s)

Servings Per Container

Not specified

Supplement Form

Tablet or Pill

Bar Code (UPC/SKU)

Not specified

Product Version

Not specified

Suggested Use

Suggested Use: Three tablets 2 to 3 times per day between meals.

Market Reference

$2.09 – $63.91· 35 listings
  • Health Concerns GB-6

    Supplement First4.9(24)
    $29.90
  • Health Concerns GB6 90 tabs

    WholeHealthResources4.9(24)
    $27.90
  • Health Concerns GB-6 90c

    OVitaminPro.com4.9(24)
    $29.90
  • Health Concerns GB-6 Capsules | TENSnet.com

    TensNet.com
    $23.92
  • Health Concerns Six Gentlemen

    Pine Street Clinic5.0(3)
    $29.90
  • Best Naturals 250 Tablets

    Best Naturals4.7(25)
    $9.99
  • Geri-Care 100 mg Strength Tablets

    Pasteur Pharmacy5.0(1)
    $2.09Lowest
  • Now B-6 100mg Veggie Caps

    All Pro Nutrition4.8(3600)
    $8.99

Where to Buy Locally

Enter your city or ZIP code to find supplement & health stores in your area that may carry this product.

Showing representative supplement & health retailers — search above for stores in your area.

Research & Studies

  • Metabolic and bariatric surgery and male endocrine and reproductive health: a GRADE-assessed meta-analysis

    R Zhu, L Li - Frontiers in Nutrition, 2026 - frontiersin.org

    … The adverse effects of obesity on male reproductive function represent a significant and growing global public health concern. MBS has garnered increasing attention for its potential as …

    2026
  • Who is Afraid of the Gallbladder? Case Series of Unmitigated Pericholecystic Microwave Ablations of Liver Tumours with Pictorial Review: U. Pisano, DH Kay: Who is …

    U Pisano, DH Kay - CardioVascular and Interventional Radiology, 2026 - Springer

    Purpose Thermal ablation of liver tumours is widely established. A location in vicinity of the gallbladder (GB) usually causes apprehension. Our intention was to gather data from our day-…

    20261 citations
  • Air conditioning and the future electricity system in Great Britain

    CH Simpson, S Halai, J Price, G Petrou… - Energy Research & …, 2026 - Elsevier

    … lead to missed decarbonisation targets or greater operational challenges, but treating low demand assumptions as constraints could lead to missed policy opportunities to protect health …

    20261 citations
  • Chemosensitization of U-87 MG glioblastoma cells by neobavaisoflavone towards doxorubicin and etoposide

    M Maszczyk, K Banach, M Karkoszka… - International Journal of …, 2022 - mdpi.com

    … The development of novel therapies in a big part concerns the application of anti-cancer agents already used in clinical practice, unfortunately often with limited effects. This could be …

    202214 citations
  • Proton beam therapy in a patient with secondary glioblastoma 32 years after postoperative radiotherapy for medulloblastoma: A case report and review of the …

    B Jiwei, M Abulimiti, J Yonglong, W Jie, Z Shuyan… - 2024 - assets-eu.researchsquare.com

    … Although the prognosis of a grade IV RIGB is poor, lessening our concerns over later clinically signi cant necrosis, it is important for physicians to optimally protect a patient's cognitive …

    2024
  • Comparison of health-related quality of life between children with cerebral palsy and spina bifida

    S Tezcan, TT Simsek - Research in developmental disabilities, 2013 - Elsevier

    This study has two aims—the first is to compare the Health Related Quality of Life (HRQoL) between children with cerebral palsy (CP) and children with spina bifida (SB); the second is …

    201323 citations

Data sourced from the U.S. National Institutes of Health, Office of Dietary Supplements Dietary Supplement Label Database (DSLD) · Label entered 2017-04-25. DSLD Label ID: 72978. This information is provided for educational reference only and is not medical advice. Always follow the product label and consult a doctor or pharmacist before use.